reviewTop 1% cited
Immune responses to human papillomavirus
Vaccine · 2005 · Vol. 24 · pp. S16–S22
Margaret Stanley✉(University of Cambridge)
Cervical Cancer and HPV ResearchHepatitis B Virus StudiesImmunotherapy and Immune ResponsesImmune systemImmunologyBiologyInnate immune systemVirusAntibodyVirologyImmunityAcquired immune systemHPV infection
MeSH terms
Antibodies, ViralClinical Trials as TopicCross ReactionsHumansImmunity, CellularViral VaccinesPapillomaviridaePapillomavirus Infections
Citations
589
FWCI
13.92
field-weighted impact
References
127
Percentile
99%
vs. same field & year
Citations per year
Cited by
Chapter 5: Updating the natural history of HPV and anogenital cancer
Vaccine · 2006 · 477 citations
References
Immunological Events in Regressing Genital Warts
American Journal of Clinical Pathology · 1994 · 486 citations
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
Virology · 1991 · 503 citations
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Vaccine · 2006 · 496 citations
The epidemiology of genital human papillomavirus infection
Vaccine · 2005 · 692 citations
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Vaccine · 2006 · 465 citations
Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer
The Journal of Infectious Diseases · 1999 · 663 citations
Related articles
Control of adaptive immunity by the innate immune system
Nature Immunology · 2015 · 2,037 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.